Relation of left ventricular thickness to age and gender in hypertrophic cardiomyopathy

被引:43
作者
Maron, BJ
Casey, SA
Hurrell, DG
Aeppli, DM
机构
[1] Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN 55407 USA
[2] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA
关键词
D O I
10.1016/S0002-9149(03)00266-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Left ventricular (LV) wall thickening is the most consistent clinical marker of hypertrophic cardiomyopathy (HC) and characteristically increases substantially during adolescence. In this study, we used 2-dimensional echocardiography to develop a cross-sectional profile of LV wall thicknesses in adult patients with HC. We studied a regional community-based cohort of 239 consecutively enrolled patients (aged 18 to 91 years). On average, maximum LV wall thickness decreased relative to increasing age (p = 0.007) within 4 age groups: 22.8 +/- 5.1 mm (18 to 39 years) to 22.1 +/- 5.1 mm (40 to 59 years) to 21.1 +/- 3.7 mm (60 to 74 years) to 20.8 +/- 3.6 mm (greater than or equal to75 years). The LV thickness index (summation Of wall thicknesses in all 4 segments) also decreased with age (p = 0.017): 63.0 +/- 12.2 mm to 59.8 +/- 11.9 mm to 58.3 +/- 10.4 mm to 57.9 +/- 9.8 mm. Decreasing magnitude of LV hypertrophy was independently associated with increasing age, but not with other relevant disease variables, such as symptoms and outflow obstruction. However, when separated by gender, this inverse relation between age and LV wall thickness was statistically significant only for women (p = 0.007). In conclusion, in an unselected HC cohort, cross-sectional analysis showed a modest but statistically significant inverse relation between age and LV hypertrophy that was largely gender-specific for women. This association constitutes another facet of the natural history of this complex and heterogenous disease and may reflect disproportionate occurrence of premature death in young patients with HC with marked hypertrophy or possibly gradual IV remodeling. (C) 2003 by Excerpta Medica, Inc.
引用
收藏
页码:1195 / 1198
页数:4
相关论文
共 30 条
[1]   Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children [J].
Charron, P ;
Dubourg, O ;
Desnos, M ;
Bouhour, JB ;
Isnard, R ;
Hagege, A ;
Carrier, L ;
Bonne, G ;
Tesson, F ;
Richard, P ;
Hainque, B ;
Schwartz, K ;
Komajda, M .
EUROPEAN HEART JOURNAL, 1998, 19 (09) :1377-1382
[2]  
Charron P, 1997, CIRCULATION, V96, P214
[3]   Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy [J].
Elliott, PM ;
Blanes, JRG ;
Mahon, NG ;
Poloniecki, JD ;
McKenna, WJ .
LANCET, 2001, 357 (9254) :420-424
[4]   Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients [J].
Elliott, PM ;
Poloniecki, J ;
Dickie, S ;
Sharma, S ;
Monserrat, L ;
Varnava, A ;
Mahon, NG ;
McKenna, WJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (07) :2212-2218
[5]   Familial hypertrophic cardiomyopathy - Cardiac ultrasonic abnormalities in genetically affected subjects without echocardiographic evidence of left ventricular hypertrophy [J].
Hagege, AA ;
Dubourg, O ;
Desnos, M ;
Mirochnik, R ;
Isnard, G ;
Bonne, G ;
Carrier, L ;
Guicheney, P ;
Bouhour, JB ;
Schwartz, K ;
Komajda, M .
EUROPEAN HEART JOURNAL, 1998, 19 (03) :490-499
[6]   PHENOTYPIC SPECTRUM AND PATTERNS OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTROPHIC CARDIOMYOPATHY - MORPHOLOGIC OBSERVATIONS AND SIGNIFICANCE AS ASSESSED BY 2-DIMENSIONAL ECHOCARDIOGRAPHY IN 600 PATIENTS [J].
KLUES, HG ;
SCHIFFERS, A ;
MARON, BJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (07) :1699-1708
[7]   Hypertrophic cardiomyopathy - A systematic review [J].
Maron, BJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (10) :1308-1320
[8]  
Maron BJ, 2000, CIRCULATION, V102, P858
[9]   Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: Hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome - A statement for healthcare professionals from the councils on clinical cardiology, cardiovascular disease in the young, and basic science, American Heart Association [J].
Maron, BJ ;
Moller, JH ;
Seidman, CE ;
Vincent, GM ;
Dietz, HC ;
Moss, AJ ;
Towbin, JA ;
Sondheimer, HM ;
Pyeritz, RE ;
McGee, G ;
Epstein, AE .
CIRCULATION, 1998, 98 (14) :1460-1471
[10]   Clinical course of hypertrophic cardiomyopathy in a regional United States cohort [J].
Maron, BJ ;
Casey, SA ;
Poliac, LC ;
Gohman, TE ;
Almquist, AK ;
Aeppli, DM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (07) :650-655